| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| jcyte phase 3 | 0.96 | 1 | 2312 | 100 | 13 |
| jcyte | 1.31 | 1 | 7632 | 92 | 5 |
| phase | 1.78 | 1 | 8253 | 77 | 5 |
| 3 | 1.14 | 0.1 | 3525 | 100 | 1 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| jcyte phase 3 | 1.76 | 0.8 | 9256 | 31 |
| jcyte phase 3 clinical trial | 0.55 | 0.7 | 2270 | 4 |
| updates on jcyte phase 3 | 0.47 | 1 | 5878 | 59 |
| clinical trial phase 3 | 0.18 | 0.3 | 2040 | 21 |
| phase 2-3 clinical trial | 1.93 | 0.1 | 3160 | 79 |
| phase i clinical trial nct02793856 | 0.1 | 0.2 | 7475 | 59 |
| phase ii/iii clinical trial | 1.13 | 0.3 | 2895 | 53 |
| clinical trial phase iii | 0.8 | 0.5 | 1537 | 36 |
| phase 3 clinical trial duration | 0.34 | 0.9 | 3695 | 67 |
| phase three clinical trial | 0.02 | 1 | 6678 | 62 |
| clinical trial phase 2 | 1.03 | 0.7 | 9070 | 73 |
| current phase 3 clinical trials | 1.04 | 0.7 | 5611 | 24 |
| phase 1 2 and 3 clinical trials | 0.06 | 0.9 | 956 | 21 |
| clinical trial phase ii | 1.6 | 0.7 | 5190 | 94 |
| clinical trials phase 1 2 3 | 1.58 | 0.5 | 9468 | 79 |
